Enhanced clearing of Helicobacter pylori after omeprazole plus roxithromycin treatment

FEMS Microbiol Lett. 1991 Dec 1;68(3):255-7. doi: 10.1016/0378-1097(91)90365-h.

Abstract

The in vitro antibacterial activity of omeprazole against eight strains of Helicobacter pylori was evaluated. Minimum inhibitory concentration (MIC) values were 32 micrograms/ml and 64 micrograms/ml (MIC50 and MIC90 respectively). We performed a randomized single blind study comparing the efficacy of omeprazole alone (for 4 weeks) or combined with roxithromycin (for 2 weeks) in the treatment of duodenal ulcer and chronic active gastritis associated with H. pylori infection, H. pylori was eradicated in 75% of patients treated with omeprazole alone whereas the patients treated with the combination of these drugs were completely free from H. pylori at the end of the therapy.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Drug Combinations
  • Duodenal Ulcer / drug therapy*
  • Gastritis / drug therapy*
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / drug effects
  • Humans
  • Omeprazole / pharmacology*
  • Roxithromycin / pharmacology*

Substances

  • Drug Combinations
  • Roxithromycin
  • Omeprazole